Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2007
08/21/2007US7258992 Reacting biological sample with a multiple epitope fusion polypeptide, detecting the presence or absence of complex, and thereby detecting the presence or absence of Streptococcus antibodies in sample
08/21/2007US7258986 Intrabodies with defined framework that is stable in a reducing environment and applications thereof
08/21/2007US7258973 Oligonucleotide sequences for use in the diagnosis and treatment of colon cancer
08/21/2007US7258971 Detecting binding of test compound to given polypeptide; use in treatment of urinary incontinence and benign prostatic hyperplasia
08/21/2007US7258866 M. canis-containing ringworm vaccine
08/21/2007US7258865 Immunogens; replication-defective; antibodies; host cells; kits
08/21/2007US7258863 Heterologous protection induced by immunization with invaplex vaccine
08/21/2007US7258861 Peptides derived from the region of human TNF- alpha from Ser100 to Glu116 to treat pulmonary oedema.
08/21/2007US7258860 Compositions and methods for the therapy and diagnosis of lung cancer
08/21/2007US7258859 Method for the treatment of multiple sclerosis
08/21/2007US7258858 Method of identifying high immune response animals
08/21/2007US7258857 Rage-related methods for treating inflammation
08/21/2007CA2247966C Murine .alpha.(1,3)fucosyltransferase fuc-tvii, dna encoding the same and uses thereof
08/21/2007CA2178517C Neisseria meningitidis capsular polysaccharide conjugates
08/21/2007CA2099069C Recombinant feline herpesvirus vaccine
08/21/2007CA2079826C Attenuated strains of aeromonas salmonicida useful as fish vaccines
08/21/2007CA2071950C Collagen binding protein as well as its preparation
08/21/2007CA2070004C Cloned glutamic acid decarboxylase
08/16/2007WO2007092772A2 Protein formulations
08/16/2007WO2007092023A1 Compositions and methods for binding or inactivating ghrelin
08/16/2007WO2007091719A1 Concomitant anti-gpvi antibody therapy and novel medicinal use thereof
08/16/2007WO2007091624A1 Novel viral vector
08/16/2007WO2007091580A1 Novel vaccine carrier
08/16/2007WO2007091395A1 Method or agent for inhibiting the function of efflux pump of pseudomonas aeruginosa
08/16/2007WO2007091030A2 Peptide sequences and compositions
08/16/2007WO2007090807A1 Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products
08/16/2007WO2007090794A1 Combinations comprising a cdk inhibitor and a growth factor antibody or anti-mitotic
08/16/2007WO2007090670A1 Treatment of metastatic breast cancer
08/16/2007WO2007090596A1 Vaccine and antigen mimotopes against cancerous diseases associated with the carcinoembryonic antigen cea
08/16/2007WO2007090294A1 Anti-bfa4 monoclonal antibodies and for cancer diagnostics and treatment
08/16/2007WO2007064844A3 Anti-viral griffithsin compounds, compositions, and methods of use
08/16/2007WO2007053446A3 Use of vaccines for the treatment/ prevention of the transmission of influenza pathogens between species
08/16/2007WO2007050702A3 Immunogenic compositions and methods of use
08/16/2007WO2007047969A3 Methods of decreasing vascular calcification using il-1 inhibitors
08/16/2007WO2007047112A3 Anti-myostatin antibodies
08/16/2007WO2007044411A3 Anti-myostatin antibodies
08/16/2007WO2007027954A3 Methods for identifying an epitope of a polypeptide, chlamydial antigenic polypeptides identified thereby, and methods of use thereof
08/16/2007WO2004089294A3 Compositions, methods and kits relating to her-2 cleavage
08/16/2007WO2004060302A3 Methods and compositions for the diagnosis, prognosis, and treatment of cancer
08/16/2007WO2004009029A3 Compositions and methods for treating and preventing infection
08/16/2007WO2004000997A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/16/2007WO2003087339A3 Spray freeze dry of compositions for pulmonary administration
08/16/2007WO2003080856A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/16/2007WO2003022226A3 Neurotrophic components of the adnf i complex
08/16/2007WO2002083916A8 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
08/16/2007WO2000000156A3 Methods for modulating immunological responses by targeting antigen to apcs in conjuction with anti-cd40 ligands
08/16/2007US20070192906 Rice plant having vaccine gene transferred thereinto
08/16/2007US20070192905 Transgenic soybean or soy protein product and a mutant cholera toxin adjuvant; the soybean is transformed with an exogenous nucleotide sequence that expresses Staphylococcus enterotoxin B; the mutant cholera toxin adjuvant is coexpressed with the SEB or is added separately
08/16/2007US20070192887 TAT-042 and methods of assessing and treating cancer
08/16/2007US20070192886 TAT-044 and methods of assessing and treating cancer
08/16/2007US20070192885 TAT-039 and methods of assessing and treating cancer
08/16/2007US20070192884 TAT-038 and methods of assessing and treating cancer
08/16/2007US20070192883 TAT-028 and methods of assessing and treating cancer
08/16/2007US20070191592 amidated peptide; stress-related conditions
08/16/2007US20070191298 Beta Secretase Genes
08/16/2007US20070191296 Diagnostics and therapeutics for diseases associated with kallikrein 13 (klk13)
08/16/2007US20070190647 Isolation and use of solid tumor stem cells
08/16/2007US20070190612 31 Human Secreted Proteins
08/16/2007US20070190561 Nucleotide sequences coding polymerase for use in identifying modulators to treat cell proliferative disorders; enzyme inhibitors; antitumor agents
08/16/2007US20070190524 Non-M, non-O HIV-1 strains, fragments and uses
08/16/2007US20070190158 Pharmaceutical compositions in particulate form
08/16/2007US20070190128 Suitable for favoring the intracellular delivery of pharmacologically active compounds, facilitating their transmembrane transport, or for promoting their interaction with specific cell membrane sites (receptors)
08/16/2007US20070190078 Filamentous haemagglutinin in the treatment and/or prophylaxis of immune-mediated disorders
08/16/2007US20070190077 Anti-HIV agents
08/16/2007US20070190076 A bacterial preparation consisting of freeze dried, non-denatured Mycobacterium bovis and water, in an amount effective to stimulate leukocytic regulatory cells, used for the prevention and/or the treatment of cancer, autoimmune diseases, allergies and tuberculosis; vaccines
08/16/2007US20070190074 Modified hpv e6 and e7 genes and proteins useful for vaccination
08/16/2007US20070190073 Bioconjugation; stimulates production of Th1-associated cytokines, lymphocytes, suppresses production of allergen-specific antibodies, reduces allergen-stimulated IgE production
08/16/2007US20070190072 In vivo efficacy of ny-eso-1 plus adjuvant
08/16/2007US20070190069 Immunotherapy for food allergy by reduced and alkylated food allergens
08/16/2007US20070190068 uPAR-binding molecule-drug conjugates and uses thereof
08/16/2007US20070190067 Cationic Steroid Antimicrobial Compositions and Methods of Use
08/16/2007US20070190066 Cationic Steroid Antimicrobial Compositions and Methods of Use
08/16/2007US20070190065 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with SARS corona virus spike protein
08/16/2007US20070190064 Enteral composition for the prevention and/or treatment of sepis
08/16/2007US20070190063 Antibody-mediated enhancement of immune response
08/16/2007US20070190062 MCM6 and MCM7 monoclonal antibodies and methods for their use in the detection of cervical disease
08/16/2007US20070190061 Peptides for stimulating an immune response against melanoma
08/16/2007US20070190060 Passive targeting of cytotoxic agents
08/16/2007US20070190059 Antithrombotic agents
08/16/2007US20070190058 Method for treating intraocular neovascular diseases
08/16/2007US20070190057 Methods for modulating mannose content of recombinant proteins
08/16/2007US20070190056 Muscle regeneration compositions and uses therefor
08/16/2007US20070190055 CCR3 inhibition for ocular angiogenesis and macular degeneration
08/16/2007US20070190054 Prevention and treatment of complement-associated disorders
08/16/2007US20070190053 Treament of lupus nephritis with anti-CD40L compounds
08/16/2007US20070190052 Regulatory CD8cells induced with anti-CD3 antibody
08/16/2007US20070190051 Administering monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents
08/16/2007US20070190050 Apparatus and method for down-regulating immune system mediators in blood
08/16/2007US20070190049 Use of A33 antigens and JAM-IT
08/16/2007US20070190048 Method of inducing physiological process in a body cavity and a device for using it
08/16/2007US20070190047 Formulations that inhibit protein aggregation
08/16/2007US20070190046 Anti-abeta antibody
08/16/2007US20070190045 Anti-CD3 and antigen-specific immunotherapy to treat autoimmunity
08/16/2007US20070190044 Compositions and methods for manipulating levels of antigen-specific antibodies in a mammal
08/16/2007US20070190043 decreasing or inhabiting hyperproliferation of keratinocytes and/or T-cells ; cream; use treating psoriasis or atopic dermatitis for example
08/16/2007US20070190034 Immunomodulation using placental stem cells
08/16/2007US20070190031 Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to hiv
08/16/2007US20070190029 Listeria-induced immunorecruitment and activation, and methods of use thereof
08/16/2007US20070190025 Method to enhance hematopoiesis
08/16/2007US20070190023 Methods and compositions for modulating the mobilization of stem cells
1 ... 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 ... 1823